Skip to main content
. 2015 Oct 29;17(Suppl 7):vii3–vii8. doi: 10.1093/neuonc/nov175

Fig. 1.

Fig. 1.

Schematic diagram of the afferent and efferent limbs of the anti-glioma immune response and where distinct immunotherapeutic modalities may act. CAR, chimeric antigen receptor.